European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology
Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee
(2021) Pediatric radiology, volume 51, issue 10, pp. 1940 - 1951
(Article)
Abstract
Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The paediatric radiologist, therefore, is an essential member of the multi-disciplinary team providing clinical care and research. This manuscript presents the
... read more
European rhabdomyosarcoma imaging guideline, based on the recently developed guideline of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Imaging Committee. This guideline was developed in collaboration between the EpSSG Imaging Committee, the Cooperative Weichteilsarkom Studiengruppe (CWS) Imaging Group, and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR). MRI is recommended, at diagnosis and follow-up, for the evaluation of the primary tumour and its relationship to surrounding tissues, including assessment of neurovascular structures and loco-regional lymphadenopathy. Chest CT along with [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT or PET/MRI are recommended for the detection and evaluation of loco-regional and distant metastatic disease. Guidance on the estimation of treatment response, optimal long-term follow-up, technical imaging settings and standardised reporting are described. This European imaging guideline outlines the recommendations for imaging in children and adolescents with rhabdomyosarcoma, with the aim to harmonise imaging and to advance patient care.
show less
Download/Full Text
Keywords: Adolescent, Child, Consensus, Diagnosis, Magnetic resonance imaging, Positron emission tomography/computed tomography, Rhabdomyosarcoma, Sarcoma, Staging, Radiology Nuclear Medicine and imaging, Pediatrics, Perinatology, and Child Health, Journal Article
ISSN: 0301-0449
Publisher: Springer-Verlag
Note: Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Collaborators: Amine Bouhamama, Department of Radiology, Centre L?on B?rard, Comprehensive Cancer Centre, Lyon, France Ana Coma, Department of Radiology, Hospital Vall d?Hebron, Barcelona, Spain Pier Luigi Di Paolo, Department or Radiology, Bambino Ges? Children?s Hospital, Rome, Italy Raquel Davila Fajardo, Department of Radiation Oncology, University Medical Centre Utrecht, and Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Christiane Franzius, Zentrum f?r Nukleramedizin und PET/CT, Zentrum f?r moderne Diagnostik (ZEMODI), Bremen, Germany Chiara Giraudo, Department of Radiology, Padua, Italy Gideon M. de Jonge, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Daniel Levine, Department of Nuclear Medicine, Royal Marsden NHS Foundation Trust, London, UK David MacVicar, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Henry Mandeville, Department of Radiotherapy, Royal Marsden Hospital, Sutton, UK Shruti Moholkar, Department of Radiology, Birmingham Children?s Hospital, Birmingham, UK Carlo Morosi, Department of Radiology, Istituto Nazionale Tumori, Milan, Italy Lil-Sophie Ording M?ller, Department of Radiology, Oslo University Hospital, Oslo, Norway Erika Pace, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Timothy N. Rogers, Department of Paediatric Surgery, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; Roberto Stramare, Department of Radiology, Padua, Italy Sheila Terwisscha van Scheltinga, Department of Paediatric Surgery, Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Nelleke Tolboom, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Publisher Copyright: © 2021, The Author(s).
(Peer reviewed)
